BioCentury
ARTICLE | Financial News

Chimerix financial update

October 14, 2013 7:00 AM UTC

Chimerix shareholders proposed to sell up to $50 million in shares in a secondary offering underwritten by Morgan Stanley and Cowen. Participating shareholders include Sanderling Venture Partners; New...